Elizabeth Annie George

About

An Assistant Professor (Junior) at Vellore Institute of Technology, specializing in microbiology and bioinformatics, with a strong focus on combating antimicrobial resistance (AMR). My research integrates genomics, systems biology, structural bioinformatics, and machine learning to develop novel therapeutic strategies targeting priority AMR pathogens. My research also investigates the mutational landscape and fitness cost of non-synonymous mutations in AMR genes, explore protein-protein and host-pathogen interactions, and identify novel drug targets. Currently, I am focused on screening, optimizing, and validating antimicrobial peptide mutants and novel inhibitor leads to counter multidrug-resistant bacterial pathogens.

Employment

• Vellore Institute of Technology University Assistant Professor (Junior)
  2026 - Present
• Vellore Institute of Technology University Teaching cum Research Assistant
  2024 - 2026
• Pushpagiri Medical College Research Trainee
  2023 - 2024

Education

• Vellore Institute of Technology University Doctor of Philosophy
  2024 - Present
• St. Berchmans College M.Sc. Microbiology
  2021 - 2023
• St. Berchmans College B.Sc. Industrial Microbiology and Zoology
  2018 - 2021

Projects & Funding

Projects & funding information is unavailable.

Publications (7)

• Exploring AI-enabled drug discovery and repurposing approaches for gastrointestinal tract cancer
  Artificial Intelligence in Gastrointestinal Cancers 2026 DOI: 10.1016/b978-0-443-44121-9.00002-0
  +Save
• Pharmacokinetics Screening, Molecular Docking, and Dynamics Simulations Revealed Novel Antimicrobial Peptide NKLF2 Mutants as Potent Inhibitors of Mycobacterium tuberculosis
  Probiotics and Antimicrobial Proteins 2026 DOI: 10.1007/s12602-025-10608-0
  +Save
• A 4-methyl-substituted durlobactam analogue as a potential class-D oxacillinase inhibitor in Acinetobacter baumannii—an in silico study
  Frontiers in Bioinformatics 2026 DOI: 10.3389/fbinf.2026.1790411
  +Save
• A review on novel strategies to combat multidrug resistance in pathogenic bacteria exploiting synergism between essential oil and antibiotics
  WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY 2026 DOI: 10.1007/S11274-025-04775-Z
  +Save
• Biofilm-associated antibiotic tolerance in the era of multidrug resistance: quorum-sensing mechanisms and emerging therapeutic strategies
  Frontiers in Cellular and Infection Microbiology 2026 DOI: 10.3389/fcimb.2026.1826282
  +Save
• Exploring AI-enabled drug discovery and repurposing approaches for gastrointestinal tract cancer
  Artificial Intelligence in Gastrointestinal Cancers 2026 DOI: 10.1016/B978-0-443-44121-9.00002-0
  +Save
• Novel antimicrobial peptide HFIAP-1 mutant as a β-lactamase inhibitor against extended-spectrum β-lactamases of Escherichia coli: a comprehensive in-silico approach
  Archives of Microbiology 2025 DOI: 10.1007/s00203-025-04483-0
  +Save